1,064 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
JNJ Johnson & Johnson $139.96 $375.48B N/A
Article Searches
Pfizer (PFE) Gets FDA Nod for Label Expansion of Prevnar 13 http://www.zacks.com/stock/news/223329/pfizer-pfe-gets-fda-nod-for-label-expansion-of-prevnar-13?cid=CS-ZC-FT-223329 Jul 13, 2016 - Pfizer Inc. (PFE) announced that the FDA has approved a label expansion of vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).
Sucampo to Stop Developing Cobiprostone for Oral Mucositis http://www.zacks.com/stock/news/223221/sucampo-to-stop-developing-cobiprostone-for-oral-mucositis?cid=CS-ZC-FT-223221 Jul 13, 2016 - Sucampo Pharmaceuticals, Inc. (SCMP) announced that it will discontinue the development of its pipeline candidate, cobiprostone.
Shire's (SHPG) Dry Eye Disease Drug Xiidra Gets FDA Nod http://www.zacks.com/stock/news/223218/shires-shpg-dry-eye-disease-drug-xiidra-gets-fda-nod?cid=CS-ZC-FT-223218 Jul 13, 2016 - Shire plc (SHPG) received a major boost when the FDA approved its ophthalmology drug Xiidra for the treatment of the signs and symptoms of dry eye disease in adults.
MedTech Industry Stock Outlook - July 2016 http://www.zacks.com/commentary/85535/medtech-industry-stock-outlook-july-2016?cid=CS-ZC--85535 Jul 11, 2016 - MedTech Industry Stock Outlook - July 2016
Johnson & Johnson (JNJ) Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3966276-johnson-and-johnson-jnj-q1-2016-results-earnings-call-transcript?source=feed_tag_transcripts Apr 19, 2016 - Johnson & Johnson (NYSE:JNJ)Q1 2016 Earnings CallApril 19, 2016 8:30 am ETExecutivesLouise Mehrotra - Vice President-Investor RelationsDominic J. Caruso - Vice President, Finance and Chief Financial O
Johnson & Johnson (JNJ) Q1 2016 Results - Earnings Call Webcast http://seekingalpha.com/article/3963663-johnson-and-johnson-jnj-q1-2016-results-earnings-call-webcast?source=feed_tag_transcripts Apr 19, 2016 - Earnings Conference Call Start time: April 19, 2016 at 08:30 AM ET.The audio will stream live while the call is active and can be replayed upon its completion.
Johnson & Johnson (JNJ) Presents at 2016 Barclays Global Healthcare Brokers Conference (Transcript) http://seekingalpha.com/article/3959350-johnson-and-johnson-jnj-presents-2016-barclays-global-healthcare-brokers-conference?source=feed_tag_transcripts Mar 17, 2016 - Johnson & Johnson (NYSE:JNJ) 2016 Barclays Global Healthcare Conference March 17, 2016 10:15 AM ET Executives Dominic Caruso - CFO J&J Ashley McEvoy - J&J’s Group Chairman for Diabetes and
Coke, P&G, JNJ: Not As 'Safe' As They Appear http://seekingalpha.com/article/3958761-coke-p-and-g-jnj-safe-appear?source=feed_all_articles Mar 16, 2016 - According to Bloomberg KO, PG, and JNJ are being avoided by big money -- a potential buy sign?However, the shares are up for the year while the S&P is down.Perhaps it's too late for the safety play.
Johnson & Johnson (JNJ) Q4 2015 Results - Earnings Call Webcast http://seekingalpha.com/article/3824396-johnson-and-johnson-jnj-q4-2015-results-earnings-call-webcast?source=feed_all_articles Jan 26, 2016 -
JNJ: Is The Company More Valuable Split Up? http://seekingalpha.com/article/3818496-jnj-company-valuable-split?source=feed_tag_long_ideas Jan 19, 2016 -
<<<Page 104>